A new clinical unit of QUINTA – ANALYTICA was officially opened in the city center of Ostrava.

The opening ceremony was attended by the company’s management, representatives of the city, deputies of hospitals of Ostrava, and health care experts. In addition to the ribbon-cutting ceremony and a tour of the new facility, the opening ceremony included a discussion among our guests on the topic of clinical trial preparation and the shortage of certain medicines in the Czech Republic.

The clinical unit in Ostrava is intended for clinical trials with healthy volunteers, which will lead to improved availability of medicines for the general public. Clinical trials will be carried out in Ostrava in a similar way to those conducted in the QUINTA-ANALYTICA clinic in Prague for the last two decades.

As part of its collaboration with the City Hospital Ostrava (MNO), the company made a financial donation in the amount of CZK 50,000 (EUR 2 000) to fully equip the waiting room of the Pediatric Department and purchase 3D virtual reality glasses that are used for invasive or traumatic procedures of pediatric patients.

Roman Grunt, CEO of QUINTA-ANALYTICA said:

The opening of the new clinic is our response to the growing demands of customers in clinical trials. After searching for a suitable location, Ostrava was the best choice for us. We are convinced that the region has the necessary qualified professionals who can not only ensure the operation of the new unit, but also provide first-class professional services which our clients from around the globe require.”

 

 

We would like to express our best wishes for the success of the clinic!

 

 

Please follow our social media pages, where we will be gradually publishing more news and a recording of the debate with our guests.

Additional News

  • 19 December 2023

    Happy new year 2024

    As we bid farewell to 2023, it's time to express our deepest gratitude for the collaboration.

  • 3 October 2023

    Meet us at the heart of Pharma, CPHI 2023

    Quinta-Analytica is attending CPHI 2023 in Barcelona

  • 18 July 2023

    Challenges of a large-scale study of breast cancer

    Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.